WCM
BSX icon

Wealthcare Capital Management’s Boston Scientific BSX Stock Holding History

Wealthcare Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-212
Closed -$8K – 158
2021
Q1 		$8K Buy
+212
New +$8.02K ﹤0.01% 302
2020
Q2 		– Sell
-99
Closed -$3K – 76
2020
Q1 		$3K Sell
99
-1
-1% -$39 ﹤0.01% 198
2019
Q4 		$5K Buy
+100
New +$4.18K ﹤0.01% 244

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Wealthcare Capital Management's BSX Position: Q2 2021 in Review

Wealthcare Capital Management sold out of Boston Scientific (BSX) in Q2 2021, closing a stake of 212 shares — an estimated $8K sold.

Wealthcare Capital Management first reported a position in BSX in Q4 2019 and held it in 3 quarters. The position peaked at $8K in Q1 2021. 867 funds tracked by Wall St. Rank hold BSX as of Q2 2021.

  • Wealthcare Capital Management reported no remaining Boston Scientific position as of Q2 2021 after selling out during the quarter.
  • Wealthcare Capital Management sold 212 Boston Scientific shares in Q2 2021, an estimated $8K.
  • Wealthcare Capital Management first reported a position in Boston Scientific in Q4 2019 and held it in 3 quarters.
  • Wealthcare Capital Management's Boston Scientific position peaked at $8K in Q1 2021.
  • 867 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2021.

Based on Wealthcare Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.